Anika Therapeutics (ANIK) Acquisitions (2020 - 2021)
Anika Therapeutics (ANIK) reported Acquisitions of $113000.0 for Q4 2021, down 84.77% year-over-year from $742000.0 in Q4 2020, and up 927.27% quarter-over-quarter from $11000.0 in Q3 2021.
Anika Therapeutics (ANIK) Acquisitions (2020 - 2021) Analysis & Trends
Anika Therapeutics (ANIK) has 2 years of Acquisitions data on file, last reported at $113000.0 in Q4 2021.
- Acquisitions for Q4 2021 came in at $113000.0, down 84.77% year-over-year; the trailing twelve-month figure through Sep 2022 was $113000.0 (down 89.77% YoY), and the FY2021 annual result was $476000.0, down 99.5% from the prior year.
- Acquisitions improved to $113000.0 in Q4 2021 per ANIK's latest filing, from $11000.0 in the prior quarter.
- Over five years, Acquisitions peaked at $93.0 million in Q1 2020 and troughed at $2000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.09 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 137.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Anika Therapeutics | 197.89 Mn | 131.10 Mn | 19.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 113,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 350,000.00 |
| Dec 31, 2020 | 742,000.00 |
| Jun 30, 2020 | 876,000.00 |
| Mar 31, 2020 | 92.98 Mn |